Evidence map›Paper›PMID 31949266›Full record

ArticleLeukemia2020

Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.

Melanie Kahl, Annamaria Brioli, Martin Bens, Florian Perner, Anne Kresinsky, Ulf Schnetzke, Anna Hinze, Yordan Sbirkov, Sven Stengel, Giorgia Simonetti and 10 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 6 countries.

Melanie KahlDepartment of Hematology/Oncology, Clinic of Internal Medicine II, Jena University Hospital, Jena, Germany.
Annamaria BrioliDepartment of Hematology/Oncology, Clinic of Internal Medicine II, Jena University Hospital, Jena, Germany.
Martin BensLeibniz-Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany.ORCID http://orcid.org/0000-0001-7940-6668
Florian PernerDepartment of Hematology/Oncology, Clinic of Internal Medicine II, Jena University Hospital, Jena, Germany.
Anne KresinskyLeibniz-Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany.
Ulf SchnetzkeDepartment of Hematology/Oncology, Clinic of Internal Medicine II, Jena University Hospital, Jena, Germany.
Anna HinzeDepartment of Hematology/Oncology, Clinic of Internal Medicine II, Jena University Hospital, Jena, Germany.
Yordan SbirkovDepartment of Medical Biology, Medical University-Plovdiv, Plovdiv, Bulgaria.
Sven StengelDepartment of Internal Medicine IV, Jena University Hospital, Jena, Germany.
Giorgia SimonettiIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Giovanni MartinelliIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Kevin PetrieSchool of Natural Sciences, University of Stirling, Stirling, UK.
Arthur ZelentMillitary Institute of Hygiene and Epidemiology, Warsaw, Poland.
Frank-Dietmar BöhmerInstitute of Molecular Cell Biology, Center for Molecular Biomedicine Jena (CMB), Jena University Hospital, Jena, Germany.
Marco GrothLeibniz-Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany.ORCID http://orcid.org/0000-0002-9199-8990
Thomas ErnstDepartment of Hematology/Oncology, Clinic of Internal Medicine II, Jena University Hospital, Jena, Germany.
Florian H HeidelDepartment of Hematology/Oncology, Clinic of Internal Medicine II, Jena University Hospital, Jena, Germany.
Sebastian SchollDepartment of Hematology/Oncology, Clinic of Internal Medicine II, Jena University Hospital, Jena, Germany.
Andreas HochhausDepartment of Hematology/Oncology, Clinic of Internal Medicine II, Jena University Hospital, Jena, Germany.
Tino SchenkDepartment of Hematology/Oncology, Clinic of Internal Medicine II, Jena University Hospital, Jena, Germany. tino.schenk@med.uni-jena.de.
Jena University Hospital · DELeibniz Institute on Aging - Fritz Lipmann Institute (FLI) · DEIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori · ITBoston Children's Hospital · USMedical University Plovdiv · BGUniversity of Stirling · GBWojskowy Instytut Higieny i Epidemiologii · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31949266
OpenAlexW2999844685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.